Calvin X. Geng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Calvin X. Geng has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Anuragh R. Gudur
Department of Medicine, University of Virginia, Charlottesville, Virginia
5 shared publications - Alexander Podboy
Department of Internal Medicine, University of Virginia, Charlottesville, VA, USA
4 shared publications Vanessa M. Shami
Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, Virginia
3 shared publicationsAlexander Podboy
2 shared publicationsAndrew Y. Wang
2 shared publications- Andrew Y. Wang
Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia
2 shared publications
Latest Publications
- Open Access
- 26 July 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (12) , 4247-4258
Adrenal Dysfunction in Outpatients with Decompensated Cirrhosis: Impairment in the Hypothalamic–Pituitary–Adrenal Axis
Background and Aims The pathogenesis of adrenal dysfunction (AD) in cirrhosis is incompletely understood. We aimed to evaluate potential effects of cirrhosis on hypothalamic–pituitary–adrenal axis (HPA) functionality in stable outpatients with decompensated disease. Methods Outpatients with decompensated cirrhosis were prospectively recruited at a transplant center. Biomarkers reflective of HPA activity, glucocorticoid synthesis, cholesterol metabolism, systemic neurohormonal activity, and the immune system were measured prior to administration of a standard-dose adrenocorticotrophic hormone (ACTH) stimulation test. Adrenal dysfunction was defined as an increase in serum total cortisol level (delta TC) of < 9 µg/dL. Patients were followed for up to 12 months for assessment of clinical outcomes including portal hypertension-related decompensation, hospitalization, liver transplant, and death. Results Seventy-six participants were enrolled (AD 33%, normal adrenal function 67%). Median ACTH levels were similar between groups (P = 0.581). The product ratio of the cortisol precursor 17-hydroxyprogesterone to 11-deoxycortisol (11-DOC) was lower in the AD group (0.9 vs. 1.3, P = 0.036), whereas the 11-DOC:cortisol ratio was similar between groups (5.9 vs. 5.0, P = 0.522). Of the 13 measured serum cytokines, only median levels of IL-6 were significantly higher in the AD group (14.71 vs. 8.99 pg/mL, P = 0.024). There were no differences in clinical outcomes between groups. Conclusions Inappropriately low ACTH secretion and alterations in adrenal steroidogenesis are associated with an abnormal response to ACTH stimulation testing in outpatients with decompensated cirrhosis. These findings suggest multilevel HPA axis dysfunction and support the theory that AD represents cirrhosis-induced extrahepatic organ failure. The presence of AD may not be associated with worse liver-related outcomes.
- 26 July 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (12) , 4247-4258
Open AccessAdrenal Dysfunction in Outpatients with Decompensated Cirrhosis: Impairment in the Hypothalamic–Pituitary–Adrenal Axis
Background and Aims The pathogenesis of adrenal dysfunction (AD) in cirrhosis is incompletely understood. We aimed to evaluate potential effects of cirrhosis on hypothalamic–pituitary–adrenal axis (HPA) functionality in stable outpatients with decompensated disease. Methods Outpatients with decompensated cirrhosis were prospectively recruited at a transplant center. Biomarkers reflective of HPA activity, glucocorticoid synthesis, cholesterol metabolism, systemic neurohormonal activity, and the immune system were measured prior to administration of a standard-dose adrenocorticotrophic hormone (ACTH) stimulation test. Adrenal dysfunction was defined as an increase in serum total cortisol level (delta TC) of < 9 µg/dL. Patients were followed for up to 12 months for assessment of clinical outcomes including portal hypertension-related decompensation, hospitalization, liver transplant, and death. Results Seventy-six participants were enrolled (AD 33%, normal adrenal function 67%). Median ACTH levels were similar between groups (P = 0.581). The product ratio of the cortisol precursor 17-hydroxyprogesterone to 11-deoxycortisol (11-DOC) was lower in the AD group (0.9 vs. 1.3, P = 0.036), whereas the 11-DOC:cortisol ratio was similar between groups (5.9 vs. 5.0, P = 0.522). Of the 13 measured serum cytokines, only median levels of IL-6 were significantly higher in the AD group (14.71 vs. 8.99 pg/mL, P = 0.024). There were no differences in clinical outcomes between groups. Conclusions Inappropriately low ACTH secretion and alterations in adrenal steroidogenesis are associated with an abnormal response to ACTH stimulation testing in outpatients with decompensated cirrhosis. These findings suggest multilevel HPA axis dysfunction and support the theory that AD represents cirrhosis-induced extrahepatic organ failure. The presence of AD may not be associated with worse liver-related outcomes.
- Open Access
- 29 August 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (9) , e01464
Aseptic Splenic Abscesses With Concomitant Sweet Syndrome as Extraintestinal Manifestations of New-Onset Crohn's Disease
Splenic abscesses are typically infectious in nature but have rarely been reported as an extraintestinal manifestation of inflammatory bowel disease, particularly of Crohn's disease. In the United States, reported cases are even more scarce. We present a case of aseptic splenic abscess with concomitant Sweet syndrome in a middle-aged woman with newly diagnosed Crohn's disease. Extensive workup was required to reach final diagnosis, and she rapidly improved with corticosteroid therapy and has been maintained on risankizumab. We aim to contribute to limited data and heighten clinician awareness of these atypical extraintestinal manifestations.
- 29 August 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (9) , e01464
Open AccessAseptic Splenic Abscesses With Concomitant Sweet Syndrome as Extraintestinal Manifestations of New-Onset Crohn's Disease
Splenic abscesses are typically infectious in nature but have rarely been reported as an extraintestinal manifestation of inflammatory bowel disease, particularly of Crohn's disease. In the United States, reported cases are even more scarce. We present a case of aseptic splenic abscess with concomitant Sweet syndrome in a middle-aged woman with newly diagnosed Crohn's disease. Extensive workup was required to reach final diagnosis, and she rapidly improved with corticosteroid therapy and has been maintained on risankizumab. We aim to contribute to limited data and heighten clinician awareness of these atypical extraintestinal manifestations.
- 23 July 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (2) , 278
Hidden in Plain Sight: Hymenolepsis Tapeworm Found on Polyp Biopsy During Routine Colonoscopy
An abstract is unavailable. This article is available as a PDF only.
- 23 July 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (2) , 278
Hidden in Plain Sight: Hymenolepsis Tapeworm Found on Polyp Biopsy During Routine Colonoscopy
An abstract is unavailable. This article is available as a PDF only.
- 1 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 1139-1145
Early safety of endoscopic sleeve gastroplasty in super obesity (body mass index > 50)
- 1 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 1139-1145
Early safety of endoscopic sleeve gastroplasty in super obesity (body mass index > 50)
- Open Access
- 15 February 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (2) , 144-154
Associations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis
Calvin X. Geng, Anuragh R. Gudur, Jagannath Kadiyala, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Alexander Podboy, Tri M. Le, Matthew Reilley, Victor Zaydfudim, Ross C.D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-136
- 15 February 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (2) , 144-154
Open AccessAssociations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis
Calvin X. Geng, Anuragh R. Gudur, Jagannath Kadiyala, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Alexander Podboy, Tri M. Le, Matthew Reilley, Victor Zaydfudim, Ross C.D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-136
- 2 October 2023
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 26 (1) , 42-45
Utilization of Through-the-scope Sutures for Complex Tissue Apposition: A Series of Novel Cases
- 2 October 2023
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 26 (1) , 42-45
Utilization of Through-the-scope Sutures for Complex Tissue Apposition: A Series of Novel Cases
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB1107
ANALYSIS OF SAFETY OF ENDOSCOPIC SLEEVE GASTROPLASTY IN SUPER OBESITY (BMI > 50): HOW HIGH CAN WE GO?
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB1107
ANALYSIS OF SAFETY OF ENDOSCOPIC SLEEVE GASTROPLASTY IN SUPER OBESITY (BMI > 50): HOW HIGH CAN WE GO?
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB1141-AB1142
ANALYSIS OF SAFETY OF ENDOSCOPIC SLEEVE GASTROPLASTY IN SUPER OBESITY (BMI > 50): HOW HIGH CAN WE GO?
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB1141-AB1142
ANALYSIS OF SAFETY OF ENDOSCOPIC SLEEVE GASTROPLASTY IN SUPER OBESITY (BMI > 50): HOW HIGH CAN WE GO?
- 1 April 2023
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 19 (10) , 1148-1153
Early safety and efficacy comparison of endoscopic bariatric interventions
- 1 April 2023
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 19 (10) , 1148-1153
Early safety and efficacy comparison of endoscopic bariatric interventions
- 27 February 2023
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (11) , 2797-2806.e6
Socioeconomic Disparities Affect Outcomes in Early-Stage Esophageal Adenocarcinoma: A SEER Analysis
- 27 February 2023
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (11) , 2797-2806.e6
Socioeconomic Disparities Affect Outcomes in Early-Stage Esophageal Adenocarcinoma: A SEER Analysis